Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2009 | 03-2009 | 01-2009 | 12-2008 | 10-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 462,300 | N/A | 515,800 | N/A | 631,400 |
| Receivables | 197,700 | N/A | 189,800 | N/A | 240,600 |
| Inventories | 149,400 | N/A | 167,200 | N/A | 162,700 |
| Other current assets | 9,300 | 0 | 10,800 | 0 | 8,000 |
| TOTAL | $852,300 | $N/A | $918,600 | $N/A | $1,077,400 |
| Non-Current Assets | |||||
| PPE Net | 168,900 | N/A | 169,300 | N/A | 177,100 |
| Investments And Advances | 77,800 | 0 | 26,700 | 0 | 0 |
| Intangibles | 99,800 | 0 | 105,800 | 0 | 520,400 |
| Other Non-Current Assets | 108,700 | 0 | 96,500 | 0 | 146,100 |
| TOTAL | $455,200 | $N/A | $398,300 | $N/A | $843,600 |
| Total Assets | $1,307,500 | $N/A | $1,316,900 | $N/A | $1,921,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,800 | N/A | N/A |
| Accounts payable and accrued liabilities | 72,500 | 0 | 75,900 | 0 | 99,100 |
| Accrued Expenses | 62,300 | N/A | 57,700 | N/A | 94,800 |
| TOTAL | $207,200 | $N/A | $212,900 | $N/A | $278,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 650,400 | N/A | 650,500 | N/A | 650,700 |
| Other Non-Current Liabilities | 83,200 | 600 | 84,000 | 700 | 78,100 |
| TOTAL | $733,600 | $N/A | $734,500 | $N/A | $728,800 |
| Total Liabilities | $940,800 | $N/A | $947,400 | $N/A | $1,006,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,624 | N/A | 96,611 | N/A | 96,447 |
| Common Shares | N/A | N/A | N/A | N/A | 23,500 |
| Retained earnings | N/A | N/A | N/A | N/A | -491,500 |
| Other shareholders' equity | 366,700 | 0 | 369,500 | 0 | -14,100 |
| TOTAL | $366,700 | $N/A | $369,500 | $N/A | $914,200 |
| Total Liabilities And Equity | $1,307,500 | $0 | $1,316,900 | $0 | $1,921,000 |